Testicular Cancer Screening Recommendations

Rationale for Not Recommending Routine Screening

The U.S. Preventive Services Task Force gives a Grade D recommendation against routine testicular self-examination (TSE) in asymptomatic adult males, meaning clinicians should actively discourage this practice in the general population 1, 2, 3.
Testicular cancer has excellent survival rates regardless of detection method, with over 90% of all newly diagnosed cases being cured, even when detected at symptomatic stages 1, 4, 5.
The disease is rare, with an annual incidence of only 5.4 cases per 100,000 males, making the absolute risk extremely low despite being the most common cancer in men aged 15-34 years 2, 6.
Most cases are discovered incidentally, and there is inadequate evidence that systematic TSE detects cancer at earlier or more curable stages compared to incidental discovery 7, 3.
The sensitivity and specificity of TSE are unknown, with no data demonstrating that TSE performed by patients or clinicians improves detection accuracy 1, 4.

False-positive results lead to unnecessary anxiety and additional testing, with diagnostic procedures carrying their own risks when pursuing false-positive findings 5, 7.
These harms outweigh the minimal to absent benefits of routine TSE, considering the low incidence and excellent prognosis of testicular cancer 5.

The American Academy of Family Physicians recommends against routine screening, consistent with the U.S. Preventive Services Task Force's Grade D recommendation 1, 8, 6.
The American Cancer Society does not recommend TSE, aligning with the consensus against routine screening in asymptomatic adult males 1, 8.
The American Academy of Pediatrics does not include TSE in preventive health recommendations, further supporting the recommendation against routine screening 1, 6.

The European Association of Urology recommends TSE for men with testicular microlithiasis (TM) and associated risk factors, such as infertility, cryptorchidism, testicular cancer history, or atrophic testes, as this may result in early detection of testicular germ cell tumors 9.
Men with isolated TM without risk factors should not undergo extensive screening, including TSE, ultrasound follow-up, or tumor markers 9.
Any man who notices testicular symptoms (mass, swelling, pain, changes in size or consistency) should immediately seek medical evaluation, as this recommendation applies only to asymptomatic screening 1, 4.